These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30858992)

  • 1. Health professionals' perspectives on breast cancer risk stratification: understanding evaluation of risk versus screening for disease.
    Puzhko S; Gagnon J; Simard J; Knoppers BM; Siedlikowski S; Bartlett G
    Public Health Rev; 2019; 40():2. PubMed ID: 30858992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the quality of deliberative stakeholder consultations involving allied health professionals in pediatric palliative care and hematology/oncology in Canada.
    Rahimzadeh V; Longo C; Gagnon J; Fernandez C; Bartlett G
    BMC Palliat Care; 2021 Dec; 20(1):189. PubMed ID: 34906102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Healthcare professionals' views following implementation of risk stratification into a national breast cancer screening programme.
    Hawkins R; McWilliams L; Ulph F; Evans DG; French DP
    BMC Cancer; 2022 Oct; 22(1):1058. PubMed ID: 36224549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The feasibility of implementing risk stratification into a national breast cancer screening programme: a focus group study investigating the perspectives of healthcare personnel responsible for delivery.
    French DP; Woof VG; Ruane H; Evans DG; Ulph F; Donnelly LS
    BMC Womens Health; 2022 May; 22(1):142. PubMed ID: 35501791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Views of health professionals on risk-based breast cancer screening and its implementation in the Spanish National Health System: A qualitative discussion group study.
    Laza-Vásquez C; Codern-Bové N; Cardona-Cardona À; Hernández-Leal MJ; Pérez-Lacasta MJ; Carles-Lavila M; Rué M;
    PLoS One; 2022; 17(2):e0263788. PubMed ID: 35120169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acceptability of risk stratification within population-based cancer screening from the perspective of healthcare professionals: A mixed methods systematic review and recommendations to support implementation.
    Taylor LC; Law K; Hutchinson A; Dennison RA; Usher-Smith JA
    PLoS One; 2023; 18(2):e0279201. PubMed ID: 36827432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "For and against" factors influencing participation in personalized breast cancer screening programs: a qualitative systematic review until March 2022.
    Laza C; Niño de Guzmán E; Gea M; Plazas M; Posso M; Rué M; Castells X; Román M
    Arch Public Health; 2024 Feb; 82(1):23. PubMed ID: 38389068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing Facilitator Fidelity to Principles of Public Deliberation: Tutorial.
    Draucker C; Carrión A; Ott MA; Knopf A
    JMIR Form Res; 2023 Dec; 7():e51202. PubMed ID: 38090788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Healthcare professionals perspectives on feasibility and acceptability of family engagement in early mobilisation for adult critically ill patients: A descriptive qualitative study.
    Mukpradab S; Cussen J; Ranse K; Songwathana P; Marshall AP
    J Clin Nurs; 2023 Sep; 32(17-18):6574-6584. PubMed ID: 36924051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barriers and Facilitators to the Implementation of a Personalized Breast Cancer Screening Program: Views of Spanish Health Professionals.
    Laza-Vásquez C; Hernández-Leal MJ; Carles-Lavila M; Pérez-Lacasta MJ; Cruz-Esteve I; Rué M; On Behalf Of The Decido Group
    Int J Environ Res Public Health; 2022 Jan; 19(3):. PubMed ID: 35162427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Communication of Pharmacogenomic test results and treatment plans in pediatric oncology: deliberative stakeholder consultations with parents.
    Longo C; Rahimzadeh V; Bartlett G
    BMC Palliat Care; 2021 Jan; 20(1):15. PubMed ID: 33435936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilizing deliberative engagement for identifying implementation strategy priorities: lessons learned from an online deliberative forum with dental professionals.
    Gruß I; Dawson T; Kaplan CD; Pihlstrom DJ; Fellows JL; Polk DE
    Implement Sci Commun; 2023 Sep; 4(1):119. PubMed ID: 37735706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delivering an iterative Communication Partner Training programme to multidisciplinary healthcare professionals: A pilot implementation study and process evaluation.
    Shrubsole K; Lin TJ; Burton C; Scott J; Finch E
    Int J Lang Commun Disord; 2021 May; 56(3):620-636. PubMed ID: 33818902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview of the epidemiology methods and applications: strengths and limitations of observational study designs.
    Colditz GA
    Crit Rev Food Sci Nutr; 2010; 50 Suppl 1(s1):10-2. PubMed ID: 21132580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acceptability of risk stratification within population-based cancer screening from the perspective of the general public: A mixed-methods systematic review.
    Taylor LC; Hutchinson A; Law K; Shah V; Usher-Smith JA; Dennison RA
    Health Expect; 2023 Jun; 26(3):989-1008. PubMed ID: 36852880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expert and Advocacy Group Consensus Findings on the Horizon of Public Health Genetic Testing.
    Modell SM; Greendale K; Citrin T; Kardia SL
    Healthcare (Basel); 2016 Jan; 4(1):. PubMed ID: 27417602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Introducing a low-risk breast screening pathway into the NHS Breast Screening Programme: Views from healthcare professionals who are delivering risk-stratified screening.
    Woof VG; McWilliams L; Donnelly LS; Howell A; Evans DG; Maxwell AJ; French DP
    Womens Health (Lond); 2021; 17():17455065211009746. PubMed ID: 33877937
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.